Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks

Behavioural Pharmacology

Volumn 17, Issue 8, 2006, Pages 681-689

  Sufka, Kenneth J ^a   Feltenstein, Matthew W ^a,b   Warnick, Jason E ^a,c   Acevedo, Edmund O ^a,d   Webb, Heather E ^a,e   Cartwright, Courtney M ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ARKANSAS TECH UNIVERSITY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Anxiety; Chick; Corticosterone; Depression; Preclinical model; Simulation

Indexed keywords

ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; CORTICOSTERONE; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CHICK; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE CLASSIFICATION; DISEASE MODEL; DISSOCIATION; DISTRESS SYNDROME; DOMESTIC ANIMAL; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; HORMONE DETERMINATION; NEUROPHARMACOLOGY; NONHUMAN; SOCIAL BEHAVIOR; VALIDATION STUDY; VALIDITY; VOCALIZATION;

ANIMALS; ANIMALS, NEWBORN; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; CHICKENS; CHLORDIAZEPOXIDE; CORTICOSTERONE; DEPRESSION; DISEASE MODELS, ANIMAL; IMIPRAMINE; MALE; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; VOCALIZATION, ANIMAL;

EID: 33751189147     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3280115fac     Document Type: Article

References (66)

1. Abelson JL, Curtis GC (1996). Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-h secretion of corticotropin and cortisol. Arch Gen Psychiatry 62:668-675.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. 4th ed. Washington, Discrict Columbia: American Psychiatric Press.
3. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999). The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1-12.
4. Baldessarini RJ (2001). Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbird LE, editors. Goodman and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill; pp. 447-483.
5. Bale TL (2006). Stress sensitivity and the development of affective disorders. Hormones Behav 50:529-533.
6. Barlow DH (2000). Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am Psychol 55:1247-1263.
7. Brown TA, Chorpita BF, Barlow DH (1998). Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol 107:179-192.
8. Brien SM, Scott LV, Dinan TG (2004). Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 19:397-403.
9. Feighner JP (1999). Overview of antidepressants currently used to treat anxiety disorders. J Clin Psychiatry 60:18-22.
10. Feltenstein MW, Sufka KJ (2005). Screening antidepressants in the chick separation-stress paradigm. Psychopharmacology (Berlin) 181:153-159.
11. Feltenstein MW, Ford NG, Freeman KB, Sufka KJ (2002). Dissociation of stress behaviors in the chick social-separation-stress procedure. Physiol Behav 75:675-679.
12. Feltenstein MW, Lambdin LC, Webb HE, Warnick JE, Khan SI, Khan IA, et al. (2003a). Corticosterone response in the chick separation-stress paradigm. Physiol Behav 78:489-493.
13. Feltenstein MW, Lambdin LC, Ganzera M, Ranjith H, Dharmaratne W, Nanayakkara NP, Khan IA, Sufka KJ (2003b). Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res 17:210-216.
14. Feltenstein MW, Warnick JE, Guth AN, Sufka KJ (2004). The chick separation stress paradigm: a validation study. Pharmacol Biochem Behav 77:221-226.
15. Frazer A, Morilak DA (2005). What should animal models of depression model? Neurosci Biobehav Rev 29:515-523.
16. Gallup GG, Suarez SD (1980). An ethological analysis of open field behaviour in chickens. Anim Behav 28:368-378.
17. Green S, Hodges H (1991). Animal models of anxiety. In: Willner P, editor. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge: Cambridge University Press; pp. 21-49.
18. Hennessy MB, Deak T, Schiml-Webb PA, Wilson SE, Greenlee TM, McCall E (2004). Responses of guinea pig pups during isolation in a novel environment may represent stress-induced sickness behaviors. Physiol Behav 81:5-13.
19. Hollon SD, Stewart MO, Strunk D (2006). Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety. Annu Rev Psychol 57:285-315.
20. Jaferi A, Bhatnagar S (2006). Cortiscosterone can act at the posterior paraventricular thalamus to inhibit hypothalamic-pituitary-adrenal activity in animals that habituate to repeated stress. Endocrinology 147:4917-4930.
21. Jaferi A, Nowak N, Bhatnagar S (2003). Negative feedback functions in chronically stressed rats: role of the posterior paraventricular thalamus. Physiol Behav 78:365-373.
22. Jiang X, Xu K, Hoberman J, Tian F, Marko AJ, Waheed JF, et al. (2005). BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30:1353-1361.
23. Kasper S (2001). Depression and anxiety: separate or continuum? World J Biol Psychiatry 2:162-163.
24. Katz R (1981). Animal models and human depressive disorders. Neurosci Biobehav Rev 20:231-246.
25. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19.
26. Kessler RC, Berglund P, Demleer O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 62:593-602.
27. Lehr E (1989). Distress call reactivation in isolated chicks: a behavioral indicator with high selectivity for antidepressants. Psychopharmacology (Berlin) 97:145-146.
28. Matthews K, Christmas D, Swan J, Sorrell E (2005). Animal models of depression: navigating through the clinical fog. Neurosci Biobehav Rev 29:503-513.
29. McArthur R, Borsini F (2006). Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 84:436-452.
30. McKinney WT, Bunney WE (1969). Animal models of depression I. review of evidence and implications for research. Arch Gen Psychiatry 21:240-248.
31. Miczek KA, Weerts EM, Vivian JA, Barros HM (1995). Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics. Psychopharmacology 121:38-56.
32. Nemeroff CB, Vale WW (2005). The neurobiology of depression: inroads to treatment and new drug discovery. J Clin Psychiatry 66:5-13.
33. Olivier B, Molewijk E, van O orschot R, van der Poel G, Zethof T, van der Heyden J, Mos J (1994). New animal models of anxiety. Eur Neuropsychopharmacol 4:93-102.
34. Panksepp J (2003). Can anthropomorphic analyses of 'separation cries' in other animals inform us about the emotional nature of social loss in humans? Psychol Rev 110:376-388.
35. Panksepp J (2006). Emotional endophenotypes in evolutionary psychology. Prog Neuropsychopharmacol Biol Psychiatry 30:774-784.
36. Panksepp J, Vilberg T, Bean NJ, Coy DH, Kastin AJ (1978). Reduction of distress vocalization in chicks by opiate-like peptides. Brain Res Bull 3:663-667.
37. Panksepp J, Meeker R, Bean NJ (1980). The neurochemical control of crying. Pharmacol Biochem Behav 12:437-443.
38. Panksepp J, Yates G, Ikemoto S, Nelson E (1991). Simple etyhological models of depression: social isolation induced despair in chicks and mice. In: Olivier O, Moss J, Slangen JL, editors. Animal models in psychopharmacology. Basel: Birkhäuser Verlag; pp. 161-181.
39. Plotsky PM, Thrivikraman KV, Meaney MJ (1993). Central and feedback regulation of hypothalamic corticotropin-releasing factor secretion. Ciba Found Symp 172:59-84.
40. Porsolt RD, LePichon M, Jalfre M (1977). Depression: a new animal model to antidepressant treatment. Nature 266:730-732.
41. Ressler KJ, Nemeroff CB (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12:2-19.
42. Reul JM, Holsboer F (2002). Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2:23-33.
43. Risbrough VB, Stein MB (2006). Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Hormones Behav 50:550-561.
44. Rivas-Vazquez RA, Saff-Biller D, Ruiz I, Blais MA, Rivas-Vazquez A (2004). Current issues in anxiety and depression: comorbid, mixed, and subthreshold disorders. Prof Psychol Res Pract 35:74-83.
45. Rodgers RJ (1997). Animal models of 'anxiety': where next? Behav Pharmacol 8:477-496.
46. Russell WMS, Burch RL (1959). The principles of humane experimental technique.London: Methuen.
47. Sapolsky RM, Armanini MP, Packan DR, Sutton SW, Plotsky PM (1990). Glucocorticoid feedback inhibition of adrenocorticotropic hormone secretagogue release. Relationship to corticosteroid receptor occupancy in various limbic sites. Neuroendocrinology 51:328-336.
48. Sarter M, Bruno JP (2002). Animal models of biological psychiatry. In: D'Haenen H, den Boer JA, Willner P, editors. Biological psychiatry. West Sussex: Wiley; pp. 1-8.
49. Seligman ME, Maier SF, Geer JH (1968). Alleviation of learned helplessness in the dog. J Abnorm Psychol 73:256-262.
50. Schiepers OJ, Wichers MC, Maes M (2005). Cytokines and major depression. Prog Neuropsychopharm Biol Psychiatry 29:201-217.
51. Smith KK, Dharmaratne HR, Feltenstein MW, Broom SL, Roach JT, Nanayakkara NP, et al. (2001). Anxiolytic effects of kava extract and kavalactones in the chick social separation-stress paradigm. Psychopharmacology (Berlin) 155:86-90.
52. Sufka KJ, Hughes RA (1991). Differential effects of handling on isolation-induced vocalizations, hypoalgesia, and hyperthermia in domestic fowl. Physiol Behav 50:129-133.
53. Sufka KJ, Weed NC (1994). Construct validation of behavioral indices of isolation stress and inflammatory nociception in young domestic fowl. Physiol Behav 55:741-746.
54. Sufka KJ, Roach JT, Chambliss WG Jr., Broom SL, Feltenstein MW, Wyandt CM, Zeng L (2001). Anxiolytic properties of botanical extracts in the chick social separation-stress procedure. Psychopharmacology (Berlin) 153:219-224.
55. Tafet GE, Bernardini R (2003). Psychoneuroendocrinological links between chronic stress and depression. Prog Neuropsychopharmacol Biol Psychiatry 27:893-903.
56. van der Staay FJ (2006). Animal models of behavioral dysfunctions: basic concepts and classifications, and an evaluation strategy. Brain Res Rev 52:131-159.
57. Warnick JE, Wicks RT, Sufka KJ (2006). Modeling anxiety-like states: pharmacological characterization of the chick separation stress paradigm. Behav Pharmacol 17:581-587.
58. Watson D (2005). Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V. J Abnorm Psychol 114:522-536.
59. Watson GS, Sufka KJ (1996). Chlordiazepoxide reverses social-separation-induced distress vocalizations and analgesia in young domestic fowl. Exp Clin Psychopharmacol 4:347-353.
60. Watson GS, Roach JT, Sufka KJ (1999). Benzodiazepine receptor function in the chick social separation-stress procedure. Exp Clin Psychopharmacol 7:83-89.
61. Willner P (1986). Validation criteria for animal modesl of human mental disorders: learned helplessness as a paradigm case. Prog Neuropsychopharmacol Biol Psychiatry 10:677-690.
62. Willner P (1991a). Behavioural models in psychopharmacology. In: Willner P, editor. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge: Cambridge University Press; pp. 3-18.
63. Willner P (1991b). Animal models of depression. In: Willner P, editor. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. Cambridge: Cambridge University Press; pp. 91-125.
64. Willner P (1997). Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 134:319-329.
65. Wright CD (2002). Animal models of depression in neuropsychopharmaology qua Feyerabendian philosophy of science. In: Shohov SP, editor. Advances in psychology research. Vol. 13. New York:NovaScience Publishers; pp. 129-148.
66. Young EA, Abelson JL, Cameron OG (2004). Effect of comorbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry 56:113-120.